首页 | 本学科首页   官方微博 | 高级检索  
检索        

替罗非班对急性冠脉综合征患者血清CRP,IL-6水平的影响
引用本文:刘欢,罗湘俊,马小峰,刘杨,周翠林.替罗非班对急性冠脉综合征患者血清CRP,IL-6水平的影响[J].医学临床研究,2009,26(7):1170-1172.
作者姓名:刘欢  罗湘俊  马小峰  刘杨  周翠林
作者单位:南华大学附属南华医院心内科,湖南,衡阳,421001
摘    要:【目的】探讨替罗非班对急性冠脉综合征(ACS)患者血清C反应蛋白(CRP)和白细胞介素6(IL-6)水平的影响。【方法】将入住本院的66例ACS患者随机分为替罗非班组(试验组)和对照组,分别检测入院即刻、治疗后24h和治疗后48h两组血清中CRP、IL-6水平,并分析两组间的相关性。【结果】替罗非班组在治疗后24h和48h血清中CRP和IL-6水平均要显著低于对照组(P〈0.05)。【结论】替罗非班能降低ACS、患者血清CRP和IL-6水平,从而抑制ACS患者炎症反应。

关 键 词:C反应蛋白质/血液  白细胞介素6/血液  冠状动脉疾病/血液  急性病  综合征  血小板膜糖蛋白类/药理学

Effects of Serum Levels of CRP and IL-6 in Patients with Acute Coronary Syndrome by Using Tirofiban
Institution:LIU Huan, LUO Xiang-jun, MA Xiao-feng,et al ( Department of Cardiology, the Affiliated Nanhua Hospital, Nanhua University, Hunan 421001, China )
Abstract:Objective] To explore the effects of serum levels of C-reactive protein (CRP) and interleukin-6 (IL-6) in patients with acute coronary syndrome by using tirofiban. Methods]CRP and IL-6 levels were examined in 66 patients with acute coronary syndrome, who were randomly divided into tirofiban treatment group and control group. Correlations were evaluated between the two groups. Results] The levels of CRP and IL-6 in tirofiban treatment group were significantly lower than those in control group (P<0.05). Conclusion] Tirofiban can inhibit inflammatory reaction by lowering levels of CRP and IL-6.
Keywords:c-reactive protein/BL  interleukin-6/BL  coronary disease/BL  acute disease  syndrome  platelet membrane glycoproteins/PD
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号